Yuki Abe

Dr. Yuki Abe


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2006 in Pediatric Nephrology
Verified
Journal Article
Closed access
PDF file
TWToru Watanabe
Toru Watanabe
YAYuki Abe
Yuki Abe
SSSeiichi Sato
Seiichi Sato
YUYumiko Uehara
Yumiko Uehara
KIKanju Ikeno
Kanju Ikeno
TATokinari Abe
Tokinari Abe

23 March 2005 in Pediatric Nephrology
Verified
Journal Article
Closed access
PDF file
TWToru Watanabe
Toru Watanabe
HYHideto Yoshikawa
Hideto Yoshikawa
SYSawako Yamazaki
Sawako Yamazaki
YAYuki Abe
Yuki Abe
TATokinari Abe
Tokinari Abe

1 July 2007 in Pediatric Nephrology
Verified
Journal Article
Closed access
PDF file
TWToru Watanabe
Toru Watanabe
YAYuki Abe
Yuki Abe
SSSeiichi Sato
Seiichi Sato
YUYumiko Uehara
Yumiko Uehara
KIKanju Ikeno
Kanju Ikeno
TATokinari Abe
Tokinari Abe

16 April 2003 in Pediatric Nephrology
Verified
Journal Article
Closed access
PDF file
TWToru Watanabe
Toru Watanabe
HYHideto Yoshikawa
Hideto Yoshikawa
YAYuki Abe
Yuki Abe
SYSawako Yamazaki
Sawako Yamazaki
YUYumiko Uehara
Yumiko Uehara
TATokinari Abe
Tokinari Abe

1 January 2007 in Hypertension Research
Verified
Journal Article
Closed access
PDF file
YAYuki Abe
Yuki Abe
TKToru Kikuchi
Toru Kikuchi
Keisuke NagasakiKeisuke Nagasaki
Keisuke Nagasaki
MHMakoto Hiura
Makoto Hiura
YTYukie Tanaka
Yukie Tanaka
MUMakoto Uchiyama
Makoto Uchiyama
The purpose of this study was to clarify the relationship between lower birth weight and current overweight status and to examine the involvement of these factors in the development of the metabolic syndrome (MS) in obese Japanese children. We examined 97 obese boys (mean age 11.3 years; mean percentage overweight [POW] 52.4%) and 29 obese girls (mean age 11.1 years; mean POW 58.3%). The anthropometric measurements, blood pressure, fasting serum insulin and blood glucose, liver enzymes, lipids and lipoproteins were measured. Birth weight and gestational weeks were also recorded. The subjects were divided into either an MS group or a Non-MS group using criteria proposed for Japanese children. We compared the weight parameters (birth weight, current weight and current weight–to−birth weight ratio [WBWR]) between the two groups and analyzed the relationships between the weight parameters and metabolic derangements. There were no significant differences in age or anthropometric measurements between the two groups. However, birth weight in the MS group was lower than that in the Non-MS group, while WBWR of the MS group was higher than that in the Non-MS group. Blood pressure and serum insulin correlated positively with WBWR. These findings suggested that lower birth weight with current overweight status was associated with the MS in obese Japanese children. We were unable to clarify whether subjects with lower birth weight who achieved proper weight gains had the same risk as subjects with appropriate birth weight. However, they should be assisted to grow adequately to prevent future metabolic derangements.

1 January 2009 in Journal of Atherosclerosis and Thrombosis
Verified
Journal Article
Open access
PDF file
YAYuki Abe
Yuki Abe
TKToru Kikuchi
Toru Kikuchi
Keisuke NagasakiKeisuke Nagasaki
Keisuke Nagasaki
MHMakoto Hiura
Makoto Hiura
YTYukie Tanaka
Yukie Tanaka
MUMakoto Uchiyama
Makoto Uchiyama
Aim: The aim of this study was to evaluate the usefulness of glutamate pyruvate transaminase (GPT) levels in the diagnosis of metabolic syndrome (MS) in obese Japanese children. Methods: We examined 193 obese boys (mean age: 12.1 yrs; mean percent overweight [POW]: 53.9%) and 37 obese girls (mean age: 11.4 yrs; mean POW: 57.2%). Anthropometric measurements, blood pressure and levels of liver transaminases, serum lipids and lipoproteins, fasting blood glucose (FBG), serum insulin and adiponectin were measured. The subjects were divided into either an MS or a non-MS group according to the MS definition criteria for Japanese children. Results: The level of GPT was significantly higher in the MS group in both genders. Correlation analysis revealed positive correlations between GPT and waist circumference, blood pressure, maximum preperitoneal fat thickness, serum insulin and homeostasis model assessment-insulin resistance (HOMA-R), but no correlation between GPT and FBG. ANOVA showed a significant difference in GPT levels between MS and non-MS subgroups, whereas there was no difference in FBG between the two groups. Receiver operating characteristic curves demonstrated that GPT was clearly superior to FBG as a diagnostic marker of MS. Conclusion: We conclude that an elevation in GPT in obese children most likely reflects insulin resistance and that GPT is superior to FBG as a marker of MS.